1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,130 | 1,350 | 12:02 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.03. | Exagen Inc. (XGN) Q4 2023 Earnings Call Transcript | 2 | Insider Monkey | ||
| 19.03. | Earnings call: Exagen Inc. reports strong 2023 revenue growth | 2 | Investing.com | ||
| 18.03. | Exagen reports Q4 results | 1 | Seeking Alpha | ||
| 18.03. | Exagen Inc reports results for the quarter ended in December - Earnings Summary | 1 | Reuters | ||
| 18.03. | EXAGEN INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| 18.03. | Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results | 93 | GlobeNewswire (Europe) | CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full... ► Artikel lesen | |
| 18.03. | EXAGEN INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.03. | Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum | 1 | GlobeNewswire (USA) | ||
| 30.01. | Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference | 4 | GlobeNewswire (USA) | ||
| 08.01. | EXAGEN INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.01. | Exagen reaffirms FY23 revenue of at least $50M | 3 | Seeking Alpha | ||
| 07.01. | Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance | 171 | GlobeNewswire (Europe) | CARLSBAD, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announces select preliminary unaudited financial results for... ► Artikel lesen | |
| 11.12.23 | EXAGEN INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.11.23 | Earnings call: Exagen reports Q3 2023 financial results, anticipates improved EBITDA in 2024 | 1 | Investing.com | ||
| 17.11.23 | Exagen files for a $150M mixed shelf offering | 1 | Seeking Alpha | ||
| 13.11.23 | Exagen Inc reports results for the quarter ended in September - Earnings Summary | 1 | Reuters | ||
| 13.11.23 | EXAGEN INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.11.23 | EXAGEN INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.11.23 | Exagen Inc. Reports Strong Third Quarter 2023 Results | 160 | GlobeNewswire (Europe) | SAN DIEGO, California, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September... ► Artikel lesen | |
| 10.11.23 | Earnings Preview For Exagen | 1 | Benzinga.com |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 12,956 | +0,93 % | Teladoc (TDOC) stock price analysis and the fall from grace | ||
| UNITEDHEALTH | 449,85 | -1,25 % | UnitedHealth Aktie: Effektive Krisenbewältigung | UnitedHealth Group hat kürzlich technische Probleme bei seiner Technologieeinheit Change Healthcare behoben, die die Verarbeitung von medizinischen Ansprüchen für einige Kunden behindert hatten. Nach... ► Artikel lesen | |
| THERMO FISHER | 534,60 | -0,96 % | Thermo Fisher Scientific-Aktie legt um 4,16 Prozent zu (531,8757 €) | An der US-amerikanischen Börse liegt das Wertpapier von Thermo Fisher Scientific gegenwärtig im Plus. Der jüngste Kurs betrug 568,99 US-Dollar. Freuen können sich gegenwärtig die Aktionäre von Thermo... ► Artikel lesen | |
| BICO GROUP | 3,766 | -2,64 % | Bico Group Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| ALIGN TECHNOLOGY | 304,80 | +3,92 % | Align Technology Inc. Q1 Profit Increases, beats estimates | WASHINGTON (dpa-AFX) - Align Technology Inc. (ALGN) announced earnings for its first quarter that increased from the same period last year and beat the Street estimates.The company's earnings... ► Artikel lesen | |
| ALCON | 74,06 | -0,51 % | Alcon Publishes Agenda for 2024 Annual General Meeting | Alcon welcomes its shareholders to its second in-person AGM In addition to the regular agenda items, shareholders to vote on the Report on Non-Financial Matters Proposed dividend... ► Artikel lesen | |
| DEXCOM | 129,54 | +0,51 % | DexCom Aktie: Umsatzstarkes Wachstum erwartet | DexCom, ein führender Anbieter von kontinuierlichen Glukoseüberwachungssystemen (CGM), hat in den vergangenen Quartalen starke Leistungen gezeigt, wobei die Expansion des Produktportfolios und die hohe... ► Artikel lesen | |
| HIMS & HERS HEALTH | 11,480 | -0,43 % | Why Hims & Hers Stock Was Down This Week | ||
| INMODE | 16,375 | +0,89 % | InMode LTD: InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M | YOKNEAM, Israel, Feb. 13, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results... ► Artikel lesen | |
| BAXTER | 38,150 | -0,27 % | Exergen Corporation: Exergen verklagt Baxter International, um sein Recht auf Veröffentlichung von Daten zur Genauigkeit von Oralthermometern zu verteidigen | Letzte Woche reichte die Exergen Corporation beim United States District Court für den District of Massachusetts eine Klage gegen Baxter International Inc. ein. Wie in der Klageschrift dargelegt,... ► Artikel lesen | |
| MCKESSON | 499,00 | -0,28 % | McKesson declares $0.62 dividend | ||
| HENRY SCHEIN | 67,26 | -1,72 % | Henry Schein (HSIC) Gears Up for Q1 Earnings: Factors to Note | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 23,880 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
| PROGYNY | 32,600 | 0,00 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,170 | 0,00 % | Where Privia Health Gr Stands With Analysts |
EXAGEN INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,260 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
